ATE229337T1 - Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend - Google Patents
Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltendInfo
- Publication number
- ATE229337T1 ATE229337T1 AT98949092T AT98949092T ATE229337T1 AT E229337 T1 ATE229337 T1 AT E229337T1 AT 98949092 T AT98949092 T AT 98949092T AT 98949092 T AT98949092 T AT 98949092T AT E229337 T1 ATE229337 T1 AT E229337T1
- Authority
- AT
- Austria
- Prior art keywords
- opioid
- antagonist
- cholecystokin
- analgesics containing
- analgesics
- Prior art date
Links
- 229940035676 analgesics Drugs 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 title 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000002051 biphasic effect Effects 0.000 abstract 1
- 239000003754 cholecystokinin receptor blocking agent Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000012074 organic phase Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721746.7A GB9721746D0 (en) | 1997-10-15 | 1997-10-15 | Compositions |
| PCT/GB1998/003076 WO1999018967A1 (en) | 1997-10-15 | 1998-10-12 | Analgesic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE229337T1 true ATE229337T1 (de) | 2002-12-15 |
Family
ID=10820524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98949092T ATE229337T1 (de) | 1997-10-15 | 1998-10-12 | Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1023072B1 (de) |
| JP (1) | JP2001519396A (de) |
| AT (1) | ATE229337T1 (de) |
| AU (1) | AU9547598A (de) |
| DE (1) | DE69810146T2 (de) |
| ES (1) | ES2189252T3 (de) |
| GB (1) | GB9721746D0 (de) |
| WO (1) | WO1999018967A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050192220A1 (en) * | 2001-02-05 | 2005-09-01 | Gevys Pharmaceuticas Ltd. | Composition and method for potentiating drugs |
| GB0201367D0 (en) * | 2002-01-22 | 2002-03-13 | Ml Lab Plc | Composition |
| US6713470B2 (en) * | 2002-01-22 | 2004-03-30 | Ml Laboratories Plc | Method of treatment |
| GB0208129D0 (en) * | 2002-04-09 | 2002-05-22 | Ml Lab Plc | Method of treatment |
| GB0207091D0 (en) * | 2002-03-26 | 2002-05-08 | Ml Lab Plc | Method of treatment |
| ITRM20020194A1 (it) | 2002-04-09 | 2003-10-09 | Sigma Tau Healthscience Spa | Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo. |
| GB0213198D0 (en) * | 2002-06-10 | 2002-07-17 | Ml Lab Plc | Method of treatment |
| AU2004257777A1 (en) * | 2003-07-14 | 2005-01-27 | Creagri, Inc. | Method of treating diabetes type II |
| JP2007509115A (ja) * | 2003-10-21 | 2007-04-12 | ソセイ・アール・アンド・ディー・リミテッド | オピエートの増強のための非オピエートの使用 |
| US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
| FR2934954B1 (fr) | 2008-08-14 | 2011-07-22 | Commissariat Energie Atomique | Emulsion fluorescente de vert d'indocyanine |
| FR2934955B1 (fr) | 2008-08-14 | 2011-07-08 | Commissariat Energie Atomique | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions |
| FR2934953B1 (fr) * | 2008-08-14 | 2011-01-21 | Commissariat Energie Atomique | Nanoemulsions de nanocristaux |
| GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| US8871791B2 (en) * | 2009-02-26 | 2014-10-28 | Teikoku Pharma Usa, Inc. | Narcotic emulsion formulations for treatment of cancer pain |
| GB201006175D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| US9132096B1 (en) | 2014-09-12 | 2015-09-15 | Alkermes Pharma Ireland Limited | Abuse resistant pharmaceutical compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1564039A (en) * | 1976-12-09 | 1980-04-02 | Berger F | Analgesic compositions comprising dextropropoxyphene and benzodiazepines |
| IE57892B1 (en) * | 1984-06-25 | 1993-05-05 | Rotta Research Lab | Glutamic and aspartic acid derivatives |
| US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
| AU614465B2 (en) * | 1989-04-05 | 1991-08-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
-
1997
- 1997-10-15 GB GBGB9721746.7A patent/GB9721746D0/en not_active Ceased
-
1998
- 1998-10-12 AT AT98949092T patent/ATE229337T1/de not_active IP Right Cessation
- 1998-10-12 JP JP2000515602A patent/JP2001519396A/ja active Pending
- 1998-10-12 DE DE69810146T patent/DE69810146T2/de not_active Expired - Fee Related
- 1998-10-12 WO PCT/GB1998/003076 patent/WO1999018967A1/en not_active Ceased
- 1998-10-12 EP EP98949092A patent/EP1023072B1/de not_active Expired - Lifetime
- 1998-10-12 ES ES98949092T patent/ES2189252T3/es not_active Expired - Lifetime
- 1998-10-12 AU AU95475/98A patent/AU9547598A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69810146D1 (de) | 2003-01-23 |
| DE69810146T2 (de) | 2003-11-13 |
| EP1023072B1 (de) | 2002-12-11 |
| AU9547598A (en) | 1999-05-03 |
| JP2001519396A (ja) | 2001-10-23 |
| ES2189252T3 (es) | 2003-07-01 |
| WO1999018967A1 (en) | 1999-04-22 |
| EP1023072A1 (de) | 2000-08-02 |
| GB9721746D0 (en) | 1997-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE229337T1 (de) | Analgetika, einen cholezystokinin antagonisten und ein opioid enthaltend | |
| EE05180B1 (et) | Asaindooli sisaldav farmatseutiline kompositsioon raviotstarbeliseks kasutamiseks, asaindoolid ning nende kasutamine ravimite valmistamiseks, mis on ette nhtud proteiinikinaasi kataltilise toime prssimiseks | |
| NZ319531A (en) | An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist | |
| ZA9710994B (en) | Pharmaceutical formulations for sustained drug delivery | |
| AU4334700A (en) | Pharmaceutical dosage form for pulsatile delivery of methylphenidate | |
| EE9700241A (et) | Farmatseutiline kompositsioon transdermaalseks manustamiseks | |
| IL135886A0 (en) | Topical compositions for nsai drug delivery | |
| DK0938316T3 (da) | Opioidantagonistholdig galenisk formulering | |
| GR1002983B (el) | Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα. | |
| EP1477119A4 (de) | Verfahren zur verabreichung von arzneimitteln | |
| ATE493115T1 (de) | Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum | |
| EP1150629A4 (de) | Vorrichtung zur dosierung für die verabreichung von steroidal aktiven wirkstoffen in die mundhöhle | |
| EP1509278A4 (de) | Implantierbare arzneimittel-abgabevorrichtung | |
| TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
| AU5072000A (en) | Pharmaceutical composition for nasally administering water-soluble active substances | |
| ITFI20000173A0 (it) | Un elettrodo ed un contenitore per la somministrazione per via transcutanea di molecole contenute in un prodotto veicolante | |
| NO20022013L (no) | Innretninger for transdermal legemiddellevering | |
| AU2001280057A8 (en) | Pharmaceutical carriers and compositions for transdermal drug delivery | |
| BR0016654A (pt) | Composto, método para o tratamento da dor, e, composição farmacêutica | |
| DE69814669D1 (de) | Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten | |
| CA89010S (en) | Injector for administration of pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1023072 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |